scispace - formally typeset
D

Deepti Pandita

Researcher at Delhi Institute of Pharmaceutical Sciences and Research

Publications -  69
Citations -  2611

Deepti Pandita is an academic researcher from Delhi Institute of Pharmaceutical Sciences and Research. The author has contributed to research in topics: Docking (molecular) & Medicine. The author has an hindex of 21, co-authored 61 publications receiving 2034 citations. Previous affiliations of Deepti Pandita include University of Virginia Health System & University of North Dakota.

Papers
More filters
Journal ArticleDOI

Dendrimers in drug delivery and targeting: Drug-dendrimer interactions and toxicity issues

TL;DR: The present review has focused on the different strategies of their synthesis, drug delivery and targeting, gene delivery and other biomedical applications, interactions involved in formation of drug-dendrimer complex along with characterization techniques employed for their evaluation, toxicity problems and associated approaches to alleviate their inherent toxicity.
Journal ArticleDOI

Solid lipid nanoparticles enhance oral bioavailability of resveratrol, a natural polyphenol

TL;DR: Stearic acid-based RLNs could act as promising sustained release system with enhanced bioavailability for resveratrol after oral administration and produce a significant 8.035 fold improvement in the oral bioavailability of resver atrol as compared to drug suspension.
Journal ArticleDOI

Functionalization of poly(amidoamine) dendrimers with hydrophobic chains for improved gene delivery in mesenchymal stem cells

TL;DR: These new vectors show a remarkable capacity for mediating the internalization of pDNA with minimum cytotoxicity, being this effect positively correlated with the -CH(2)- content present in the hydrophobic corona.
Journal ArticleDOI

Updates on Aldose Reductase Inhibitors for Management of Diabetic Complications and Non-diabetic Diseases.

TL;DR: Adapting ARIs could prevent sepsis complications, prevent angiogenesis, ameliorate mild or asymptomatic diabetic cardiovascular autonomic neuropathy and appear to be a promising strategy for the treatment of endotoxemia and other ROS-induced inflammatory diseases.
Journal ArticleDOI

Non-Viral Gene Delivery to Mesenchymal Stem Cells: Methods, Strategies and Application in Bone Tissue Engineering and Regeneration

TL;DR: An overview of the application of chemical and physical methods for non-viral gene delivery to MSCs is given and their use in tissue engineering and regenerative medicine therapeutic strategies highlighted using the example of bone tissue.